Hinova Pharmaceuticals Inc. A (688302) — Financial Flexibility Index
Hinova Pharmaceuticals Inc. A (688302) has a Financial Flexibility Index of -0.58x as of December 2024. Free cash flow of CN¥-97.53 Million (operating CF CN¥-187.08 Million minus capex CN¥89.55 Million) represents -1% of total liabilities (CN¥169.33 Million). Check 688302 financial resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hinova Pharmaceuticals Inc. A Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Hinova Pharmaceuticals Inc. A across 6 annual periods. See working capital position of Hinova Pharmaceuticals Inc. A to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hinova Pharmaceuticals Inc. A (2019–2024)
Year-by-year free cash flow to debt coverage for Hinova Pharmaceuticals Inc. A. For the full company profile including market capitalisation, see Hinova Pharmaceuticals Inc. A stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.58x | CN¥-97.53 Million | CN¥-187.08 Million | CN¥169.33 Million | ▲ +54.1% |
| 2023 | -1.26x | CN¥-156.33 Million | CN¥-255.51 Million | CN¥124.47 Million | ▲ +23.5% |
| 2022 | -1.64x | CN¥-245.72 Million | CN¥-314.92 Million | CN¥149.68 Million | ▼ -52.7% |
| 2021 | -1.07x | CN¥-208.05 Million | CN¥-227.82 Million | CN¥193.59 Million | ▲ +9.8% |
| 2020 | -1.19x | CN¥-241.16 Million | CN¥-243.66 Million | CN¥202.33 Million | ▼ -19.5% |
| 2019 | -1.00x | CN¥-80.30 Million | CN¥-81.43 Million | CN¥80.50 Million | — |